Smoking Vaping and Edibles All Feel Different for a Reason

[Riff]

Smoking and vaping deliver cannabinoids through pulmonary absorption, producing effects within minutes that typically last one to three hours. Edibles follow an entirely different pathway, requiring gastrointestinal processing and hepatic metabolism, which converts THC into 11-hydroxy-THC before entering systemic circulation. This metabolic transformation explains the delayed onset of 30 minutes to two hours and extended duration of four to eight hours. Each format carries distinct bioavailability implications that every consumer should understand before choosing a product.

Smoking vs Vaping vs Edibles: What Makes Each Format Different​

Although smoking, vaping, and edible cannabis products share cannabinoids as their active compounds, each format delivers those compounds through distinct physiological pathways that directly influence how quickly cannabinoids enter the bloodstream, how much reaches systemic circulation, and how long effects persist. Inhalation methods introduce cannabinoids directly into the lungs, enabling rapid absorption into systemic circulation. Edibles require gastrointestinal processing and hepatic metabolism, fundamentally altering cannabinoid profiles before reaching circulation. These mechanical differences largely explain why cannabis experiences vary across formats even when THC content appears comparable. Product formulations, terpenes impact on absorption, and cannabinoid profiles further complicate direct comparisons. Individual variability—including metabolism, tolerance, and consumption preferences—means two people using identical products through the same format may still describe meaningfully different outcomes.

Onset and Duration Across Cannabis Consumption Methods​

When cannabinoids enter the body, how quickly they reach peak plasma concentration—and how long they remain pharmacologically active—depends almost entirely on which delivery pathway the product uses. Inhalation—whether through smoking or vaping—typically produces onset timing within minutes, as cannabinoids transfer rapidly across lung tissue into systemic circulation. Duration effects for inhaled formats generally range from one to three hours. Edible cannabis follows a considerably different pharmacokinetic profile. Cannabinoids absorbed through the gastrointestinal tract undergo hepatic first-pass metabolism, converting THC into 11-hydroxy-THC before entering circulation. This process delays onset timing to anywhere between 30 minutes and two hours post-consumption. Duration effects for edibles frequently extend four to eight hours. These distinctions are format-driven, not potency-driven, and understanding them helps consumers set accurate expectations before use.

Why THC Percentage Doesn't Tell the Whole Story​

THC percentage measures cannabinoid concentration by dry weight, but concentration alone does not determine how much THC actually reaches systemic circulation—or in what form. Bioavailability varies considerably across consumption formats. Inhaled cannabis delivers cannabinoids rapidly through pulmonary absorption, while edibles convert THC into 11-hydroxy-THC during hepatic metabolism—a structurally distinct compound associated with different cannabinoid effects. A product labeled 30% THC flower and a 10mg edible are not comparable through percentage alone because delivery mechanisms, metabolic pathways, and absorption rates differ fundamentally. Terpene composition, cannabinoid ratios, product formulation, and individual physiology further influence outcomes. Consumers anchoring consumption preferences exclusively to THC percentage risk misaligned expectations. Cannabinoid percentage is one data point—not a complete predictor of how any format will perform within any individual system.

Five Myths About Smoking, Vaping, and Edibles​

Misinformation about cannabis consumption formats persists partly because surface-level observations—smoke looks like vapor, edibles contain the same cannabinoids as flower—obscure meaningful mechanistic differences. Five myths consistently distort consumption preferences and user experience:

Myth 1: One format is objectively superior. No universal hierarchy exists; suitability depends on individual circumstances.

Myth 2: THC percentage predicts outcomes. Bioavailability, metabolism, and formulation matter considerably more.

Myth 3: Vaping and smoking are identical. Combustion and vaporization produce chemically distinct aerosols at different temperatures.

Myth 4: Edibles are simply amplified smoking. Hepatic metabolism converts THC differently, producing distinct pharmacokinetic profiles.

Myth 5: Higher doses guarantee stronger effects. Individual tolerance, endocannabinoid system variability, and consumption context all modulate outcomes regardless of stated cannabinoid content.

Cannabis Product Labels: What to Read Before You Buy​

Clearing up myths about cannabis formats addresses the "why" behind user experiences, but practical purchasing decisions depend equally on understanding what product labels actually communicate. Cannabis labeling on licensed products typically includes total THC and CBD content, serving size, and net weight — data points that directly inform dosing decisions. Bioavailability differs across formats, meaning the same milligram quantity produces distinct absorption rates depending on whether the product is inhaled or ingested. Certificates of Analysis (COAs) from third-party laboratories verify cannabinoid concentrations and confirm contaminant testing. Product transparency through COA access allows consumers to cross-reference label claims against independently verified data. Onset windows and recommended serving sizes, when listed, reflect format-specific absorption timelines. Reading labels before purchasing remains the most mechanistically sound step toward format-appropriate, dose-informed consumption decisions.